Home › Funds › EASTERN BANK › RPRX

EASTERN BANK position in RPRX

ROYALTY PHARMA PLC · Health Care

EASTERN BANK reported holding 708,768 shares of RPRX (ROYALTY PHARMA PLC) in its Q3 2026 13F filing — a position valued at US$41.4M, representing 0.63% of its reported portfolio and ranking #45 among its reported holdings. EASTERN BANK has disclosed RPRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)708.77K sh
Reported value held$41.36M
Portfolio Weight0.63%
First reportedQ3 2023
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How EASTERN BANK's RPRX position evolved

EASTERN BANK first disclosed a stake in RPRX in Q3 2023 at 76,983 shares (US$2.1M). The position peaked in Q3 2026 at 708,768 shares, worth US$41.4M. Across 13 filings, EASTERN BANK increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 708,768 shares valued at US$41.4M — an increase of 13,843 shares quarter over quarter.. Notable position changes include a 52% trim in Q1 2025 (shares rose 16% over the following quarter), a 1368% increase in Q3 2025 (shares rose 10% over the following quarter), a 71% increase in Q4 2025 (shares rose 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 76.98K $2.09M New
Q4 2023 65.67K $1.84M Reduce
Q1 2024 56.90K $1.73M Reduce
Q2 2024 56.49K $1.49M Reduce
Q3 2024 55.97K $1.58M Reduce
Q4 2024 55.31K $1.41M Reduce
Q1 2025 26.44K $823.20K Reduce
Q2 2025 25.29K $911.09K Reduce
Q3 2025 371.25K $13.10M Add
Q4 2025 635.12K $24.54M Add
Q1 2026 659.38K $31.63M Add
Q2 2026 694.92K $38.96M Add
Q3 2026 708.77K $41.36M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RPRX and 13F data

RPRX (ROYALTY PHARMA PLC) is a Health Care company. 50 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$601.4M), Baillie Gifford & Co (US$561.6M), Caledonia (Private) Investments Pty Ltd (US$323.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RPRX

All RPRX fund holders →

FAQ

How long has EASTERN BANK held RPRX?

EASTERN BANK has disclosed RPRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EASTERN BANK's current position in RPRX?

As of Q3 2026, EASTERN BANK holds 708.77K shares of RPRX (ROYALTY PHARMA PLC), valued at $41.36M, representing 0.63% of its reported portfolio and ranking #45.

Has EASTERN BANK been buying or selling RPRX?

In the latest 13F filing (Q3 2026), EASTERN BANK increased its position in RPRX. The position peaked in Q3 2026 at 708.77K shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, Caledonia (Private) Investments Pty Ltd, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.